Skip to main content
SpringerLink
Log in

Cardiac Failure

  • Chapter
Cardiovascular Disease

Part of the book series: Treatment in Clinical Medicine ((TC MEDICINE))

  • 435 Accesses

Abstract

The clinical syndrome of cardiac failure has long been recognised, but its management remains one of the major problems in clinical cardiology. About one-quarter of patients with cardiovascular disease have heart failure and the long-term prognosis is determined by the degree to which cardiac performance is impaired (Klainer et al. 1965). Recent innovations in the investigation of cardiac patients have increased our understanding of the mechanism of cardiac failure and aided the development of a logical approach to its long-term management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Armstrong PW, Armstrong JA, Marks GS (1980) Pharmacokinetic-haemodynamic studies of nitroglycerin ointment in congestive heart failure. Am J Cardiol 46: 670–676

    Article  PubMed  CAS  Google Scholar 

  • Arnold SB, Byrd RC, Meister W et al. (1980) Long-term digitalis therapy in left ventricular function in heart failure. N Engl J Med 303:1443–1448

    Article  PubMed  CAS  Google Scholar 

  • Awan NA, Miller R, De Maria AN, Maxwell KS, Newmann A, Mason DT (1977) Efficacy of ambulatory systemic vasodilator therapy with oral Prazosin in chronic refractory heart failure. Circulation 56: 346–354

    PubMed  CAS  Google Scholar 

  • Bourdillon PDV, Dawson JR, Foale RA, Timmis AD, Poole-Wilson PS, Sutton GC (1980) Salbutamol in treatment of heart failure. Br Heart J 43: 206–210

    Article  PubMed  CAS  Google Scholar 

  • Chatterjee K, Parmley WW, Massie B et al. (1976) Oral hydralazine therapy for chronic refractory heart failure, Circulation 54: 879–883

    PubMed  CAS  Google Scholar 

  • Chatterjee K, Massie B, Rubin S et al. (1978) Long-term outpatient vasodilation therapy of congestive heart failure: consideration of agents at rest and during exercise. Am J Med 65: 134–145

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN, Franciosa JA (1977) Vasodilator therapy of cardiac failure. N Engl J Med 297:27–31; 254–258

    Article  PubMed  CAS  Google Scholar 

  • Davis JO, Freeman RH (1976) Mechanisms regulating renin release. Physiol Review 56: 1–56

    CAS  Google Scholar 

  • Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Prakash R, Swan HJC (1973) Renal and extrarenal haemodynamic effects of furosemide in congestive heart failure after myocardial infarction. N Engl J Med 288: 1087–1090

    Article  PubMed  CAS  Google Scholar 

  • Erdmann E, Brown L (1983) The cardiac glycoside-receptor system in the human heart. Eur Heart J 4 (Supple A): 61–65

    PubMed  CAS  Google Scholar 

  • Fabiato A, Fabiato F (1979) Calcium and cardiac excitation-contraction coupling. Ann Rev Physiol 41: 473–484

    Article  CAS  Google Scholar 

  • Firth BG, Delmar CJ, Corbett JR, Lewis SE, Parkey RW, Willerson JT (1980) Effect of chronic oral digoxin therapy on ventricular function at rest and peak exercise in patients with ischaemic heart disease. Am J Cardiol 46: 481–490

    Article  PubMed  CAS  Google Scholar 

  • Hillis WS, Been M (1982) Phosphodiesterase inhibitors, haemodynamic effects related to the treatment of cardiac failure. Eur Heart J 3: 97–103

    PubMed  CAS  Google Scholar 

  • Hutton I, Murray RG, Boyes RN, Rae AP, Hillis WS (1980) Haemodynamic effects of prenalterol in patients with coronary heart disease Br Heart J 43: 134–137

    Article  PubMed  CAS  Google Scholar 

  • Katz AM, Smith VE (1982) Regulation of myocardial function in the normal and diseased heart: modification by inotropic drugs. Eur Heart J 3 (Suppl): 11–19

    PubMed  CAS  Google Scholar 

  • Klainer LM, Gibson TC, White KL (1965) The epidemiology of cardiac failure. J Chron Dis 18: 797–814

    Article  PubMed  CAS  Google Scholar 

  • Kleimann JH, Ingels NB, Daughters G, Stinson EB, Alderman EL, Goldmann RH (1978) Left ventricular dynamics during long-term digoxin treatment in patients with stable coronary artery disease. Am J Cardiol 41: 937–943

    Article  Google Scholar 

  • Klein W, Brandt D, Maurer E (1981) Haemodynamic assessment of prenalterol: a cardioselective beta-agonist in patients with impaired left ventricular function. Clin Cardiol 94: 325–329

    Google Scholar 

  • Lal S, Murtagh JG, Pollock AM, Fletcher E, Binnion PF (1969) Acute haemodynamic effects of frusemide in patients with normal and raised left atrial pressure. Br Heart J 31: 711–717

    Article  PubMed  CAS  Google Scholar 

  • Levine TB, Franciosa JA, Cohn JN (1980) Acute and long-term response to an oral converting enzyme inhibitor Captopril, in congestive heart failure. Circulation 62: 35–41

    PubMed  CAS  Google Scholar 

  • Malliani A (1982) Cardiovascular sympathetic afferent fibres. Rev Physiol Biochem Pharmacol 94: 11–74

    Article  Google Scholar 

  • Mason DT (1967) Control of peripheral circulation in health and disease. Mod Concepts Cardiovasc Dis 36: 25–28

    Google Scholar 

  • Massie B, Ports T, Chatterjee K (1981) Long-term vasodilator therapy for heart failure: clinical response and its relationship to haemodynamic measurements. Circulation 63: 269–278

    Article  PubMed  CAS  Google Scholar 

  • Mathey D (1980) Hydralazine in chronic left heart failure. Cardiology 65: 55–57

    Article  PubMed  Google Scholar 

  • Miller RR, Williams DO, Mason DT (1976a) Pharmacological mechanisms for LV unloading in clinical congestive heart failure: differential effects of nitroprusside, phentolamine and nitroglycerin on cardiac function and peripheral circulation. Circ Res 39: 127–133

    PubMed  CAS  Google Scholar 

  • Miller RR, Vismara LA, Williams DO, Amsterdam EA, Mason DT (1976b) Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Circ Res 39:127-133

    PubMed  CAS  Google Scholar 

  • Mills CJ, Cabe IJ, Mason DT (1970) Pressure flow relationships and vascular impedance in man. Cardio vase Res 4: 405–417

    Article  CAS  Google Scholar 

  • Nellis SH, Flaim SF, McCauley K, Zelis R (1980) Alpha-stimulation protects exercise increment in skeletal muscle oxygen consumption. Am J Physiol 238: 331–339

    Google Scholar 

  • Nelson GIC, Silke B, Ahuja RC, Taylor SH (1982a) Arterial dilatation or venodilatation following frusemide in acute heart failure following myocardial infarction. Clin Sci 63: 3P

    Google Scholar 

  • Nelson GIC, Silke B, Barker MCJ, Saxton CAPD, Taylor SH (1982b) A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure. Eur Heart J 3: 238–245

    PubMed  CAS  Google Scholar 

  • Nicholls MG, Espiner EA, Donald RA, Hughes H (1974) Aldosterone and its regulation during diuresis in patients with gross congestive heart failure. Clin Sci Mol Med 47: 301–315

    PubMed  CAS  Google Scholar 

  • O’Rourke RA, Hening H, Theroux P, Crawford MH, Ross J Jr (1976) Favourable effect of orally adminstered digoxin on left heart size and ventricular wall motion in patients with previous myocardial infarction. Am J Cardiol 37: 708–716

    Article  PubMed  Google Scholar 

  • Packer M, Meller J, Gorlin R, Herman MV (1979) Haemodynamic and clinical tachyphylaxis to prazosin mediated afterload reduction in severe chronic congestive heart failure. Circulation 59: 531–539

    PubMed  CAS  Google Scholar 

  • Scholz H (1983) Pharmacological actions of various inotropic drugs Eur Heart J 4: 161–173

    PubMed  CAS  Google Scholar 

  • Sharpe DN, Douglas JE, Coxon RJ, Long B (1980) Low dose Captopril in chronic heart failure: acute haemodynamic effects and long-term treatment. Lancet II: 1154–1157

    Article  Google Scholar 

  • Silke B, Hendry WG, Taylor SH (1981) Immediate and sustained haemodynamic effects of prazosin during upright exercise in man. Br Heart J 46: 663–670

    Article  PubMed  CAS  Google Scholar 

  • Skou JC (1957) The influence of some cations on an adenosine triphosphate from peripheral nerves. Biochem Biophys Acta 23: 349–401

    Article  Google Scholar 

  • Sonnenblick EH, Le Jemtel TH (1982) Newer inotropic agents in congestive heart failure. In: Braunwald E, Mokk MB, Watson J (eds) Congestive heart failure, current research and clinical applications. Grune-Stratton, New York, pp 291–302

    Google Scholar 

  • Sonnenblick EH, Spiro D, Spotnitz HM (1964) Ultrastructural basis of Starling’s law of the heart; role of sarcomere in determining ventricular size and stroke volume. Am Heart J 68: 336–346

    Article  PubMed  CAS  Google Scholar 

  • Spann JF, Buccino RA, Sonnenblick EA (1967) Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circ Res 21: 341–354

    PubMed  Google Scholar 

  • Taylor SA, Silke B, Nelson GK (1982) Principles of treatment of left ventricular failure. Eur Heart J 3: 19–43

    PubMed  Google Scholar 

  • Watkins L Jr, Burton JA, Cant JR, Smith FW, Barger AC (1976) The renin angiotensin aldosterone system in congestive failure in conscious dogs. J Clin Invest 57: 1606–1617

    Article  PubMed  CAS  Google Scholar 

  • Wikman-Coffelt J, Parmley WW, Mason DT (1979) The cardiac hypertrophy process: analysis of factors determining pathological v physiological development. Circ Res 45: 697–707

    PubMed  CAS  Google Scholar 

  • Zelis R, Mason DT, Braunwald E (1968) A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 47: 960–970

    Article  PubMed  CAS  Google Scholar 

  • Zelis R, Delea CS, Comeman et al. (1970) Arterial sodium content in experimental congestive heart failure. Circulation 41: 213–216

    PubMed  CAS  Google Scholar 

  • Zelis R, Flaim SF (1982) Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 24: 437–459

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal Infirmary, Castle Street, Glasgow, Scotland, UK

    A. Ross Lorimer MD, FRCP (Consultant Cardiologist)

  2. Stobhill General Hospital, Glasgow, G21 2UW, Scotland, UK

    W. Stewart Hillis MB, FRCP (Senior Lecturer in Clinical Pharmacology and Consultant Cardiologist)

Authors
  1. A. Ross Lorimer MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Stewart Hillis MB, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lorimer, A.R., Hillis, W.S. (1985). Cardiac Failure. In: Cardiovascular Disease. Treatment in Clinical Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-3120-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3120-5_9

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-15426-6

  • Online ISBN: 978-1-4471-3120-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation